Chabiotech Co.,Ltd. (KOSDAQ:085660)
15,480
-160 (-1.02%)
At close: Dec 5, 2025
Chabiotech Market Cap
Chabiotech has a market cap or net worth of 1.18 trillion as of December 5, 2025. Its market cap has increased by 24.13% in one year.
Market Cap
1.18T
Enterprise Value
2.11T
Revenue
1.20T
Ranking
n/a
PE Ratio
n/a
Stock Price
15,480.00
Market Cap Chart
Since February 23, 2009, Chabiotech's market cap has increased from 334.13B to 1.18T, an increase of 251.89%. That is a compound annual growth rate of 7.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 1.18T | 83.30% |
| Dec 30, 2024 | 641.46B | -41.85% |
| Dec 28, 2023 | 1.10T | 50.82% |
| Dec 29, 2022 | 731.49B | -34.83% |
| Dec 30, 2021 | 1.12T | 6.53% |
| Dec 30, 2020 | 1.05T | 39.68% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 76.57T |
| Celltrion | 40.11T |
| ALTEOGEN | 27.92T |
| ABL Bio | 11.08T |
| SK Biopharmaceuticals | 10.61T |
| Yuhan | 8.91T |
| LigaChem Biosciences | 6.91T |
| Peptron | 6.67T |